These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2947744)

  • 1. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
    Tarazi RC; Frohlich ED
    Circulation; 1987 Jan; 75(1 Pt 2):I113-7. PubMed ID: 2947744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of left ventricular hypertrophy: a desirable therapeutic goal?
    Schmieder RE; Messerli FH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S16-22. PubMed ID: 1707110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of left ventricular hypertrophy: do antihypertensive classes differ?
    Sheridan DJ
    J Hypertens Suppl; 2000 Jul; 18(3):S21-7. PubMed ID: 10952084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamics and other determinants in development of left ventricular hypertrophy.
    Frohlich ED
    Fed Proc; 1983 Jul; 42(10):2709-15. PubMed ID: 6222919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive treatment and remission of left ventricular hypertrophy. Critical study].
    Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():39-43. PubMed ID: 2150473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
    Schmieder RE; Messerli FH
    Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of myocardial and coronary effects of arterial hypertension].
    Strauer BE; Motz W; Vogt M
    Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of cardiac hypertrophy by medical treatment.
    Tarazi RC; Fouad FM
    Annu Rev Med; 1985; 36():407-14. PubMed ID: 3158269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment.
    Safar ME; Toto-Moukouo JJ; Bouthier JA; Asmar RE; Levenson JA; Simon AC; London GM
    Circulation; 1987 Jan; 75(1 Pt 2):I156-61. PubMed ID: 2947747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heart in hypertension.
    Frohlich ED
    Clin Nephrol; 1991 Oct; 36(4):160-5. PubMed ID: 1835683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy: an independent risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S59-66; discussion S66-7. PubMed ID: 1726010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of cardiovascular structural changes during long-term antihypertensive therapy.
    Agabiti-Rosei E; Muiesan ML
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():41-7. PubMed ID: 1834845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coronary circulation in cardiac hypertrophy.
    Sheridan DJ; McAinsh A; O'Gorman DJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S18-28. PubMed ID: 7508057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.